{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:05:12Z","timestamp":1790611512481,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nuclcard.2025.102473","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:25:23Z","timestamp":1758590723000},"page":"102473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["SNMMI\/EANM\/ASNC\/ACNM procedure standard\/practice guideline for 18F-Flurpiridaz PET myocardial perfusion imaging and blood flow quantitation"],"prefix":"10.1016","volume":"53","author":[{"given":"Ren\u00e9 R. Sevag","family":"Packard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid","family":"Maddahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Pelletier-Galarneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouaz H.","family":"Al-Mallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Dorbala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Galt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandakumar","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinali","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Saraste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nuclcard.2025.102473_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jacc.2013.11.009","volume":"63","author":"Wolk","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib2","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.jacc.2021.07.052","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/HCO.0b013e328349803b","article-title":"Radionuclide cardiac stress testing","volume":"26","author":"Badheka","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.pcad.2015.03.004","article-title":"Radionuclide myocardial perfusion imaging for the evaluation of patients with known or suspected coronary artery disease in the era of multimodality cardiovascular imaging","volume":"57","author":"Taqueti","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.nuclcard.2025.102473_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0002-9149(79)80005-3","volume":"43","author":"Gould","year":"1979","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9149(79)80006-5","article-title":"Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography","volume":"43","author":"Schelbert","year":"1979","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib7","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.CIR.63.6.1259","article-title":"N-13 ammonia as an indicator of myocardial blood flow","volume":"63","author":"Schelbert","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2025.102473_bib8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0002-9149(82)90045-5","article-title":"Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography","volume":"49","author":"Schelbert","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib9","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/01.CIR.80.5.1328","article-title":"13N-ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography","volume":"80","author":"Krivokapich","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2025.102473_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0735-1097(89)90105-8","article-title":"Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography","volume":"14","author":"Bergmann","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2967\/jnumed.117.201368","article-title":"Clinical quantification of myocardial blood flow using PET: joint position paper of the SNMMI cardiovascular council and the ASNC","volume":"59","author":"Murthy","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2967\/jnumed.120.246280","article-title":"Appropriate use criteria for PET myocardial perfusion imaging","volume":"61","author":"Schindler","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2967\/jnumed.124.269154","article-title":"FDA approval of 18F-flurpiridaz for PET: stepping into a new era of myocardial perfusion imaging?","volume":"66","author":"Schindler","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/j.semnuclmed.2011.02.004","article-title":"The next generation of cardiac positron emission tomography imaging agents: discovery of flurpiridaz F-18 for detection of coronary disease","volume":"41","author":"Yu","year":"2011","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib15","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2023.08.016","article-title":"Flurpiridaz F-18 PET myocardial perfusion imaging in patients with suspected coronary artery disease","volume":"82","author":"Maddahi","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib16","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2967\/jnumed.114.141093","article-title":"Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F-18 PET","volume":"55","author":"Packard","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2967\/jnumed.120.252007","article-title":"Diagnostic performance of PET versus SPECT myocardial perfusion imaging in patients with smaller left ventricles: a substudy of the 18F-flurpiridaz phase III clinical trial","volume":"62","author":"Packard","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102166","article-title":"F-18-Flurpiridaz positron emission tomography myocardial perfusion imaging clinical results in specific patient populations","volume":"45","author":"Patel","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2012.11.022","article-title":"Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F-18 positron emission tomography","volume":"61","author":"Berman","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2020.05.063","article-title":"Phase-III clinical trial of fluorine-18 flurpiridaz positron emission tomography for evaluation of coronary artery disease","volume":"76","author":"Maddahi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib21","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/ehjci\/jeab267","article-title":"18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization","volume":"23","author":"Packard","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102473_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44161-024-00587-w","article-title":"The clinical promise of 18F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease","volume":"4","author":"Packard","year":"2025","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.nuclcard.2025.102473_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102167","article-title":"Potential worldwide impact of F-18 flurpiridaz positron emission tomography myocardial perfusion imaging","volume":"45","author":"Al-Mallah","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib24","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.nuclcard.2007.07.009","article-title":"Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent","volume":"14","author":"Yalamanchili","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.nuclcard.2007.07.008","article-title":"BMS-747158-02: a novel PET myocardial perfusion imaging agent","volume":"14","author":"Yu","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2967\/jnumed.107.044727","article-title":"Initial characterization of an 18F-labeled myocardial perfusion tracer","volume":"49","author":"Huisman","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib27","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1161\/CIRCULATIONAHA.108.797761","article-title":"Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model","volume":"119","author":"Nekolla","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2025.102473_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/CIRCIMAGING.108.815423","article-title":"Evaluation of a novel 18F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats","volume":"2","author":"Sherif","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102473_bib29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2967\/jnumed.110.083196","article-title":"Simplified quantification of myocardial flow reserve with flurpiridaz F 18: validation with microspheres in a pig model","volume":"52","author":"Sherif","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1088\/0031-9155\/44\/3\/019","article-title":"Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution","volume":"44","author":"Levin","year":"1999","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.semnuclmed.2014.06.011","article-title":"Cardiac PET perfusion tracers: current status and future directions","volume":"44","author":"Maddahi","year":"2014","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s11886-022-01713-5","article-title":"The potential of F-18 flurpiridaz PET\/CT myocardial perfusion imaging for precision imaging","volume":"24","author":"Patel","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.nuclcard.2025.102473_bib33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2967\/jnumed.121.263507","article-title":"Radiotracers to address unmet clinical needs in cardiovascular imaging, part 1: technical considerations and perfusion and neuronal imaging","volume":"63","author":"Stendahl","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib34","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2967\/jnumed.111.092528","article-title":"Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest","volume":"52","author":"Maddahi","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib35","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s12350-018-01484-z","article-title":"Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging","volume":"26","author":"Maddahi","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102175","article-title":"18F flurpiridaz PET MPI: imaging characteristics and clinical trials","volume":"45","author":"Maddahi","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib37","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s12350-020-02034-2","article-title":"Added value of myocardial blood flow using 18F-flurpiridaz PET to diagnose coronary artery disease: the flurpiridaz 301 trial","volume":"28","author":"Moody","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib38","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1007\/s12350-021-02837-x","article-title":"Impact of residual subtraction on myocardial blood flow and reserve estimates from rapid dynamic PET protocols","volume":"29","author":"Poitrasson-Rivi\u00e8re","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib39","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00259-021-05643-2","article-title":"Improved myocardial blood flow estimation with residual activity correction and motion correction in 18F-flurpiridaz PET myocardial perfusion imaging","volume":"49","author":"Otaki","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2025.102473_bib40","article-title":"F-18 flurpiridaz positron emission tomography myocardial perfusion imaging combined with treadmill exercise testing","volume":"45S","author":"Bourque","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib41","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2025.102473_bib42","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0735-1097(00)01029-9","volume":"36","author":"Rodgers","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib43","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s12350-015-0387-x","article-title":"ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers","volume":"23","author":"Henzlova","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib44","first-page":"S146","article-title":"Establishing a PET\/CT practice","volume":"184","author":"Shreve","year":"2005","journal-title":"Am J Rev"},{"key":"10.1016\/j.nuclcard.2025.102473_bib45","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s12350-018-01548-0","article-title":"Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR","volume":"26","author":"Abidov","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102072","article-title":"Automatic motion correction for myocardial blood flow estimation improves diagnostic performance for coronary artery disease in 18F-flurpiridaz positron emission tomography-myocardial perfusion imaging","volume":"44","author":"Builoff","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib47","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s12350-020-02335-6","article-title":"Development, diagnostic performance, and interobserver agreement of a 18F-flurpiridaz PET automated perfusion quantitation system","volume":"29","author":"Packard","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib48","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2967\/jnumed.115.164285","article-title":"Dual-gated motion-frozen cardiac PET with flurpiridaz F 18","volume":"56","author":"Slomka","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib49","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1007\/s00259-025-07174-6","article-title":"Subendocardial quantification enhances coronary artery disease detection in 18F-flurpiridaz PET","volume":"52","author":"Builoff","year":"2025","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2025.102473_bib50","article-title":"Quantitative approaches to 18F-flurpiridaz positron emission tomography image analysis","volume":"45S","author":"Packard","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American heart association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2025.102473_bib52","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib53","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s12350-017-1049-y","article-title":"Technical aspects of acquiring and measuring myocardial blood flow: method, technique, and QA","volume":"25","author":"Votaw","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11886-019-1096-x","article-title":"Quantification of PET myocardial blood flow","volume":"21","author":"Pelletier-Galarneau","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.nuclcard.2025.102473_bib55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00259-023-06455-2","article-title":"Integrated myocardial flow reserve (iMFR) assessment: optimized PET blood flow quantification for diagnosis of coronary artery disease","volume":"51","author":"Poitrasson-Rivi\u00e8re","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2025.102473_bib56","doi-asserted-by":"crossref","unstructured":"Packard RRS, Buckley C, Cooke CD, et al. Comparison, agreement, and significance cutoffs of 18F-flurpiridaz PET myocardial blood flow quantitation methods and software packages. J Nucl Med 2025;66(11):1674\u201382. https\/\/doi.org\/10.2967\/jnumed.124.269398.","DOI":"10.2967\/jnumed.124.269398"},{"key":"10.1016\/j.nuclcard.2025.102473_bib57","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jcmg.2025.03.011","article-title":"Established and emerging fluorine-18-labeled cardiac PET radiotracers","volume":"18","author":"Packard","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102473_bib58","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1007\/s12350-022-03089-z","article-title":"2022 ASNC\/AAPM\/SCCT\/SNMMI guideline for the use of CT in hybrid nuclear\/CT cardiac imaging","volume":"29","author":"Al-Mallah","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib59","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1007\/s12350-023-03378-1","article-title":"Atlas for reporting PET myocardial perfusion imaging and myocardial blood flow in clinical practice: an information statement from the American Society of Nuclear Cardiology","volume":"30","author":"Chareonthaitawee","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib60","first-page":"613","article-title":"The radiation dosimetry of 2-[F-18]fluoro-2-deoxy-D-glucose in man","volume":"23","author":"Jones","year":"1982","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcmg.2017.06.006","article-title":"Cardiac-specific conversion factors to estimate radiation effective dose from dose-length product in computed tomography","volume":"11","author":"Trattner","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102473_bib62","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00259-020-05046-9","article-title":"EANM procedural guidelines for PET\/CT quantitative myocardial perfusion imaging","volume":"48","author":"Sciagr\u00e0","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2025.102473_bib63","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s12350-010-9244-0","article-title":"Recommendations for reducing radiation exposure in myocardial perfusion imaging","volume":"17","author":"Cerqueira","year":"2010","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib64","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033566","article-title":"Influence of body mass index on radiation exposure across imaging modalities in the evaluation of chest pain","volume":"13","author":"Sperry","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nuclcard.2025.102473_bib65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12350-012-9523-z","article-title":"Patient-centered imaging","volume":"19","author":"Depuey","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102473_bib66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2967\/jnumed.119.226498","article-title":"First human imaging studies with the EXPLORER total-body PET scanner","volume":"60","author":"Badawi","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib67","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2967\/jnumed.123.266858","article-title":"Total-body PET\/CT applications in cardiovascular diseases: a perspective document of the SNMMI cardiovascular council","volume":"65","author":"Slart","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102473_bib68","first-page":"1718","article-title":"\u201cUpward creep\u201d of the heart: a frequent source of false-positive reversible defects during thallium-201 stress-redistribution SPECT","volume":"30","author":"Friedman","year":"1989","journal-title":"J Nucl Med"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358125003472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358125003472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T11:52:36Z","timestamp":1766145156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358125003472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":68,"alternative-id":["S1071358125003472"],"URL":"https:\/\/doi.org\/10.1016\/j.nuclcard.2025.102473","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SNMMI\/EANM\/ASNC\/ACNM procedure standard\/practice guideline for 18F-Flurpiridaz PET myocardial perfusion imaging and blood flow quantitation","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2025.102473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Society of Nuclear Cardiology.","name":"copyright","label":"Copyright"}],"article-number":"102473"}}